During the past decade, Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders" are "Mucopolysaccharidosis II" (2 trials) and "Mucopolysaccharidosis Type II (MPS II)" (1 trials). Many other conditions were trialed in "Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders" in a lesser frequency.

Most popular intervention types in "Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders" are "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Long-term Follow-Up" (1 trials) and "RGX-121" (1 trials). Other intervention names were less common.

The vast majority of trials in "Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders" are 3 trials for "Male" genders.

Currently, there are NaN active trials in "Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".